Do diagnostic prescribed activities (dosages) of 131I cause stunning or not? In the first part of this section, Drs. Park and Gerard present arguments supporting the presence of stunning secondary to the administration of diagnostic dosages of 131I, and in the second section, Dr. McDougall presents arguments against the presence of stunning as a significant issue. In the end, each physician will most likely select the information that one believes makes the stronger argument or best supports one's prior viewpoint. However, a third viewpoint exists to either a yes or no answer. It is a compromised viewpoint that holds: Diagnostic doses of 131I result in a spectrum ranging from no stunning to significant stunning and even treatment. © 2006 Humana Press Inc.
CITATION STYLE
Van Nostrand, D. (2006). Stunning: Does it exist? a commentary. In Thyroid Cancer (Second Edition): A Comprehensive Guide to Clinical Management (pp. 349–350). Humana Press. https://doi.org/10.1007/978-1-59259-995-0_38
Mendeley helps you to discover research relevant for your work.